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Mouse Embryonic Fibroblasts Devoid of both Mitofusin1 and Mitofusin2
can Acutely Shift from Glycolytic to Oxidative Metabolism
Erin Seifert, Cynthia Moffat, Ewa Strus.
Thomas Jefferson University, Philadelphia, PA, USA.
Much progress has been made in the identification of proteins that mediate
mitochondrial fusion, as well as in the elucidation of their role in mitochondrial
quality control. Yet, while deficiency of mitochondrial fusion seems to
induce a mitochondrial dysfunction suggesting a requirement of fusion for
oxidative metabolism, the cause of the dysfunction is unclear. We have
undertaken a bioenergetics analysis to understand the basis of the mitochondrial
dysfunction, using intact mouse embryonic fibroblasts deficient in mitofusin1
and mitofusin2 (DKO) incubated under conditions replete in glycolytic vs.
oxidative substrate. We first noted an approximate doubling of the non-
mitochondrial oxygen consumption (JO2) in DKO cells compared to wild-
type (Wt) MEFs, regardless of substrate. Upon switching from primarily
glycolytic to more oxidative conditions, DKO MEFs, similar to the Wt, in-
creased basal mitochondrial JO2 (oligomycin-sensitiveþoligolycin-insensitive,
non-mitochondrial subtracted), although the rise was smaller in DKO cells (an
increase of 55511 vs. 114511 pmoles/min/40k cells in DKO vs. Wt; values:
mean5sem). When only the oligomycin-sensitive respiration is considered,
the rise was similar in DKO cells (an increase of 121.3510 vs. 135.8513
pmoles O2/min/40k cells in DKO vs. Wt), whereas the oligomycin-sensitive
JO2 decreased in DKO cells only (by ~50%). In both Wt and DKO cells, the
rate of media acidification declined upon switching from glycolytic to oxidative
substrate, indicating a shift from glycolytic to oxidative ATP production. Thus,
as in Wt MEFs, DKOMEFs demonstrate a basal mitochondrial respiration con-
trolled by ATP turnover and substrate oxidation. Differently from the Wt, DKO
mitochondria can exert a significant control of basal JO2 by proton leak, which
could function to compensate for any limitation in mitochondrial capacity.
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Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative dis-
ease characterized by a progressive loss of motor neurons and muscle atrophy.
Accumulation of mutant superoxide dismutase (SOD1) in mitochondria impairs
mitochondrial function and has been proposed as a potential trigger of the dis-
ease. To study the dynamic function of mitochondria in ALS, we generated
a double transgenic (dTG) mouse model (G93A/mt-cpYFP) overexpressing
an ALS mutant (SOD1G93A) and a novel mitochondrion-targeted superoxide
biosensor (mt-cpYFP). Characterized by its reversible kinetics, mt-cpYFP
has been shown as a valuable tool that allows real-time imaging and quantifica-
tion of the dynamic superoxide bursts in mitochondria, termed ‘‘flashes’’
(Wang 2008; Fang 2011). Here we show that, compared to wild type (WT) con-
trols expressing mt-cpYFP, there is an increased mitochondrial superoxide pro-
duction in skeletal muscle derived from the dTG mice which occurred before
the onset of ALS disease. This is manifested by a significant increase in the am-
plitude of the flash signal (aF/F0 = 0.8750.04, N=71, 5 dTGmice; 0.6450.06,
N=21, 2 WT mice; P=0.015), as well as an increase in the ratio of flashing area
to cell area in fibers from the ALS mice (dTG: 2.350.29, N= 71, 5 mice; WT:
1.250.18, N=42, 3 mice; P=0.008). In contrast, there is no significant change in
the flash frequency and duration between ALS mice and controls, suggesting
that the stereotype of the flash signal is maintained in the diseased muscle.
The increased superoxide generation in mitochondria could be a contributing
factor for muscle degeneration during ALS progression. The molecular mech-
anisms that contribute to this increased superoxide production in the diseased
muscle are under investigation. Supported by MDA and NIAMS/NIH.
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SOD1G93A Mutant forms Aggregates Inside Mitochondria and Alters
Mitochondrial Structure and Dynamics in Skeletal Muscle
Guo Luo1, Jianxun Yi1, Yajuan Xiao1, Frank Yi1, Tian Yu2, Jingsong Zhou1.
1Rush University, Chicago, IL, USA, 2Zunyi Medical College, Zunyi, China.
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular degenerative dis-
ease. Mutations in SOD1 (superoxide dismutase 1) is a major cause for most
familial ALS. The transgenic mouse model (G93A) overexpressing mutantSOD1G93A recapitulates many features of the human disease. Immunohisto-
chemical analysis of motor neurons in G93A mice showed accumulation of
SOD1 inside swollen mitochondria (Deng 2006). Our earlier study also found
similar morphological changes in skeletal muscle of G93A mice (Zhou 2010).
SOD1 is a cytosolic protein with a small portion inside mitochondria under
normal conditions. To elucidate why mutant SOD1 causes mitochondrial dys-
function, we targeted SOD1 directly into mitochondria by making constructs
(mt-SOD1-Dendra andmt-SOD1G93A-Dendra) with addition of a mitochondrial
targeting peptide at the N-terminus of SOD1/SOD1G93A and a photoswitchable
fluorescent protein (Dendra2, Addgene) at the C-terminus. Those constructs
were acutely expressed in skeletal muscle of normal mice. 7 days after trans-
fection, muscle fibers expressing SOD1G93A showed aggregated fluorescent
proteins inside mitochondria (SOD1G93A: 91%, n= 24; SOD1: 0%, n=16) and
3-fold more fibers with fragmented mitochondria (SOD1G93A: 67%; SOD1:
19%). Mitochondrial dynamics was also evaluated. After Dendra was photo-
converted from green to red in a fiber area (~ 10 mm x 10 mm), the migration
of Dendra out of the original area was evaluated in both longitudinal and trans-
versal directions. Migration over one sarcomere distance (~2.2 mm) was defined
as one migration step (ms). A significant reduction of mitochondrial dynamics
was found in fibers expressing SOD1G93A (1.45 0.3 ms, n=7) compared with
SOD1 (5.15 1.2ms, n=8) in 20 min. The result is consistent with the finding in
G93A mice. While normal fibers showed 18.7 5 2.3 ms of mitochondrial
migration (n=13), G93A fibers only showed 2.05 0.4 ms (n=12).
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There is emerging evidence that stem cells can rejuvenate damaged cells by
mitochondrial transfer. Here we show that Miro1, a calcium sensor that regu-
lates mitochondrial movement in neurons, mediates mitochondrial transfer by
mesenchymal stem cells (MSC) and determines their repair potential. MSC
overexpressing Miro1 (MSC-Miro-Hi) show enhanced mitochondrial transfer
and rescue of stressed epithelial cells, while MSC lacking Miro1 (MSC-Miro-
Lo) were ineffective. Other Miro1 expressing mesenchymal-origin cells like
fibroblasts could also donate mitochondria to stressed epithelial cells, with
low levels of Miro1. The therapeutic relevance was tested in mouse models
of rotenone induced airway injury and asthma, which has earlier been associated
with epithelial mitochondrial dysfunction. Miro1 levels and mitochondrial-
donor capacity of MSC were directly related to attenuation of apoptosis, airway
hyperresponsiveness and remodeling. In both models, treatment with MSC-
Miro-Hi was associated with better outcomes, and MSC-Miro-Lo with worse
outcomes, compared to control MSC. In summary, our work provides new
understanding regarding how mitochondrial transfer from stem cells happens,
shows that other mesenchymal origin cells may share this property, provides
definitive evidence that mitochondrial transfer is essential for stem cell medi-
ated rescue in mouse models of asthma and airway injury, and most importantly
enables strategies for increasing the repair potential of stem cells.
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VDAC1-Based Peptides: Novel Pro-Apoptotic Agents and a Potential
Therapeutic Drug for B-Cell Chronic Lymphocytic Leukemia
Varda Shoshan-Barmatz, Tal Prazma, Anna Shteinfer, Lee Admoni,
Ilan Sela.
Ben-Gurion University, Beer Sheva, Israel.
VDAC1 at the outer mitochondrial membrane allows for exchange of
metabolites between the mitochondrion and the cytoplasm, thus assuming
a fundamental role in cell energy metabolism. VDAC1 is also a key player
in mitochondria-mediated apoptosis, controlling the release of mitochondrial
apoptogenic proteins such as cytochrome c (Cyt c) and interacts with anti-
apoptotic proteins, hexokinase (HK) and Bcl-2 family proteins. Overexpression
of these anti-apoptotic proteins is thought to underlie anti-apoptotic defense
mechanisms of cancer cells, including B-cell chronic lymphocytic leukemia
(CLL). CLL is characterized by clonal expansion of mature B cells that occurs
mainly due to the inability of these cells to undergo apoptosis. using specifi-
cally designed VDAC1-based cell-penetrating peptides we targeted the anti-
apoptotic proteins to prevent their anti-apoptotic activity. In this study, we
demonstrate that the VDAC1-based peptides selectively kills peripheral blood
